Literature DB >> 16382004

Evaluation of pituitary function in the fatigued patient: a review of 59 cases.

Jerry R Greenfield1, Katherine Samaras.   

Abstract

OBJECTIVE: The aim of this study was to review the results of dynamic pituitary testing in patients presenting with fatigue.
METHODS: We reviewed clinical histories and insulin tolerance test (ITT) results of 59 patients who presented with fatigue and other symptoms of glucocorticoid insufficiency over a 4-year period. All patients referred for ITT had an early-morning cortisol level of <400 nM and a low or normal ACTH level.
RESULTS: Peak cortisol and GH responses following insulin-induced hypoglycaemia were normal in only seven patients (12%). Median age of the remaining 52 patients was 47 years (range, 17-67 years); all but five were female. Common presenting symptoms were neuroglycopaenia (n = 47), depression (n = 37), arthralgia and myalgia (n = 28), weight gain (n = 25), weight loss (n = 9), postural dizziness (n = 15) and headaches (n = 13). Other medical history included autoimmune disease (n = 20; particularly Hashimoto's thyroiditis, Graves' disease and coeliac disease), postpartum (n = 8) and gastrointestinal (n = 2) haemorrhage and hyperprolactinaemia (n = 13). 31 subjects had peak cortisol levels of <500 nM (suggestive of ACTH deficiency; 18 of whom had levels < 400 nM) and a further six had indeterminate results (500-550 nM). The remaining 15 subjects had normal cortisol responses (median 654 nM; range, 553-1062 nM) but had low GH levels following hypoglycaemic stimulation (5.9 mU/l; 3-11.6 mU/l).
CONCLUSION: Our results suggest that patients presenting with fatigue and symptoms suggestive of hypocortisolism should be considered for screening for secondary adrenal insufficiency, particularly in the presence of autoimmune disease or a history of postpartum or gastrointestinal haemorrhage. Whether physiological glucocorticoid replacement improves symptoms in this patient group is yet to be established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16382004     DOI: 10.1530/eje.1.02010

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  2 in total

1.  Suppression of HPA axis in adults taking inhaled corticosteroids.

Authors:  J R Greenfield; K Samaras
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

2.  Diagnoses during follow-up of patients presenting with fatigue in primary care.

Authors:  Iris Nijrolder; Daniëlle van der Windt; Henk de Vries; Henriëtte van der Horst
Journal:  CMAJ       Date:  2009-10-26       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.